Tona M. Gilmer,Peter F. Lebowitz,Li Liu,Jolly Mazumdar
申请号：
US13988054
公开号：
US20130231346A1
申请日:
2011.11.17
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Methods for treating a human with cancer comprise administering a therapeutically effective amount of at least one MEK inhibitor and at least one mTOR inhibitor to said patient, wherein said patient has at least one mutation in at least one Ras protein or gene encoding at least one Ras protein and/or wherein said patient has at least one mutation, deletion or insertion in LKB1/STK11.
